Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy R Jass

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Surgical Oncology|November 21, 2007
Molecular heterogeneity of colorectal cancer: Implications for cancer controlJeremy R Jass
Pathology, Research and Practice|June 11, 2008
Colorectal polyposes: from phenotype to diagnosisJeremy R Jass
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literatureJoanne Young, Jeremy R Jass
The Lancet. Oncology|March 22, 2002
Emerging pathways in colorectal-cancer developmentAndrew M M Haydon, Jeremy R Jass
International Journal of Cancer|December 14, 2007
Colorectal cancer cells express functional cell surface-bound TGFbetaKristi Baker, Pooja Raut, Jeremy R Jass
Cancer Immunology, Immunotherapy : CII|May 20, 2008
MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cellsKristi Baker, William D Foulkes, Jeremy R Jass
Virchows Archiv : an International Journal of Pathology|August 4, 2007
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancerInti Zlobec, Luigi Terracciano, Jeremy R Jass, et al.
Gastroenterology Clinics of North America|March 4, 2008
Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical managementJames E East, Brian P Saunders, Jeremy R Jass
Journal of Clinical Pathology|December 22, 2006
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerInti Zlobec, Russell Steele, Luigi Terracciano, et al.
Human Pathology|February 3, 2007
Recommendations for the reporting of surgically resected specimens of colorectal carcinomaJeremy R Jass, Michael J O'Brien, Robert H Riddell, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Surgical Oncology|November 21, 2007
Molecular heterogeneity of colorectal cancer: Implications for cancer controlJeremy R Jass
Pathology, Research and Practice|June 11, 2008
Colorectal polyposes: from phenotype to diagnosisJeremy R Jass
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literatureJoanne Young, Jeremy R Jass
The Lancet. Oncology|March 22, 2002
Emerging pathways in colorectal-cancer developmentAndrew M M Haydon, Jeremy R Jass
International Journal of Cancer|December 14, 2007
Colorectal cancer cells express functional cell surface-bound TGFbetaKristi Baker, Pooja Raut, Jeremy R Jass
Cancer Immunology, Immunotherapy : CII|May 20, 2008
MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cellsKristi Baker, William D Foulkes, Jeremy R Jass
Virchows Archiv : an International Journal of Pathology|August 4, 2007
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancerInti Zlobec, Luigi Terracciano, Jeremy R Jass, et al.
Gastroenterology Clinics of North America|March 4, 2008
Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical managementJames E East, Brian P Saunders, Jeremy R Jass
Journal of Clinical Pathology|December 22, 2006
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerInti Zlobec, Russell Steele, Luigi Terracciano, et al.
Human Pathology|February 3, 2007
Recommendations for the reporting of surgically resected specimens of colorectal carcinomaJeremy R Jass, Michael J O'Brien, Robert H Riddell, et al.
Pageof 8